The healthcare community is intrigued by retatrutide, a new dual GIP and GLP-1 target that’s showing impressive results in clinical research. This compound works by replicating natural hormones to impact appetite and increase feelings of satiety, ultimately leading substantial fat reduction . While still under investigation and not broadly avail… Read More